Citigroup’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-50,000
Closed -$1.2M – 5653
2025
Q1
$1.2M Buy
+50,000
New +$1.76M ﹤0.01% 3119

Other funds holding BHVN

Citigroup's BHVN Position: Q3 2026 in Review

Citigroup reduced its Biohaven (BHVN) stake by 75% in Q3 2026, selling an estimated $3.42M and leaving 78,110 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3286.

Citigroup first reported a position in BHVN in Q3 2022 and has held it in 17 quarters since. The position peaked at $9.05M in Q1 2024. 120 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • Citigroup held 78,110 shares of Biohaven worth $1.04M as of Q3 2026.
  • Citigroup sold 236,343 Biohaven shares in Q3 2026, an estimated $3.42M.
  • Biohaven made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3286 holding.
  • Citigroup first reported a position in Biohaven in Q3 2022 and has held it in 17 quarters since.
  • Citigroup's Biohaven position peaked at $9.05M in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.